The emergency use approval for Bharat’s Covaxin will mean millions of Indians can soon travel and could also be a major boost for low-income countries desperate for vaccines. Host Marco Werman speaks to Prashant Yadav, a senior fellow at the Center for Global Development about why this vaccine made it on the World Health Organization’s list and what that could mean for global COVID-19 vaccine supply.